Will Last Week's Biotech IPO Outperform in a Recession?

Will Last Week's Biotech IPO Outperform in a Recession?

Source: 
Motley Fool
snippet: 

Cancer drug developer Oric Pharmaceuticals (NASDAQ:ORIC) successfully raised $120 million in its IPO on Friday, and the stock posted a splashy opening-day gain of 61%. Here are a few reasons why this company was so appealing to investors, even during this time of crisis.